Professional Documents
Culture Documents
21-05-2012
( )
( )
Ma
AFP
, 70 KD
Ca 125
,
200KD
Ca 15.3
,
>250 KD
Ca 72.4
, 48KD
Ca 19.9
Lewis, 1000 KD
CEA
, 180 KD
CYFRA
21.1
19, 30 KD
HCG
2 ,
36KD
NSGCT,
, ,
NSE
, 87KD
SCLC, ,
PLAP
, 86KD
PSA
, 36KD
SCC
, 48 KD
TPA
8,18,19, 22KD
TPS
18, 22KD
K
AFP : t1/2: 4-5
( ,
, )
HCG: ,
, t1/2: 24-30
(,
)
,
)
LDH :
i (36%):
LDH, -HCG
(64%):
: -HCG
:
AFP
:
AFP, -HCG
AFP
HCG
FSH, LH TSH
-
-
-
HCG + HCG
HCG ( HCG)
, ,
HCG ( HCG)
(
)
: ,
(10-30%),
,
Ka
-CG
-CG
10
CEA
CEA (carcinoembryonic antigen)
52-77%
61-68%
40-60%
40-60%
80%
50-70%
30-50%
47-50%
27%
47-50%
27%
11
CEA
12
CEA -
(>5)
( 80% - 70%)
-
13
Ca 19-9
81%, 90%
,
, .. , ,
(55% <3 cm )
14
Ca 19-9
Ca 19-9
15
16
Ca
SCC (squamous cell carcinoma antigen):)
SCC a ,
-,
, ,
(CYFRA 21-1, TPA, TPS)
A
Ca19-9
17
AFP
AFP (alpha-fetoprotein):
= 40-65%,
= 76-96%
sAg
3
C
= 52% (>3cm), 25%
(<3cm)
( >
)
L3, P4 P5
>400 ng/ml :
Ca
18
Ca 15-3, CEA, MCA, BR27-29, BRMA, CA549
Ca 15-3 (MUC-1):
UC1 MCA,
15-35%
19
40-
60% - 5,2
60-80%
,
20
CEA
test
MUC1
,
CA15-3/BR27-29
CA15-3/BR27-29
21
Ca-125
Ca-125 :
22
Ca 125
Ca 125
50%
90%
92.1%
93.9%
23
CA125 ...
Ca
24%
10%
31-33%
40%
25%
8%
17-20%
15%
100%
52-58%
10%
29-37%
32%
50-78%
2%
15%
30%
46%
10%
67%
24
Ca-125
ECHO
>90%
25
K
Ka
SCC
Ca 125 ()
Ca 125
26
PSA
PSA ( o ):
10 PSA
.
27
PSA
;
PSA > 4 ng/ml
.
PSA,
.
PSA: PSA
0,35-0,4 ng/ml/ Ca
2 ng/ml/
28
PSA
10-12
PSA
PSA
(75%)
X PSA
29
Ka
:
NSE (neuron specific enolase, 87kD)
CEA (carcinoembryonic antigen)
CYFRA21-1 (cytokeratin 19 fragments, 30kD)
SCC (squamous cell carcinoma antigen)
30
Ka
NSE : SCLC
SCC (>2ng/ml) : SCLC (95%)
(80%)
Ca o Ca
31
(Tg):
Tg r-TSH
Tg:
:
Tg r-TSH :
6-24
(>5-10 ng/ml)
:
Tg:
32
()
(:
)
FNA
:
(,
Ca):
C
(SCLC,
, ,
, ,
Zollinger)
( ,
)
Tests :
, Ca++
33
(5-10% )
34
,
.
, ,
,
.
35
36
37